Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Community Mental Health Journal
|
August 11, 2018
Factors Associated with Rapid Readmission Among Nevada State Psychiatric Hospital Patients
Christopher Owen Moore, Sheniz Moonie, Julia Anderson
Pain
|
February 1, 1997
Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics: use of pain intensity and visual analogue scales
Andrew Moore, Owen Moore, Henry McQuay, et al.
Frontiers in Psychiatry
|
September 3, 2025
Modified electroconvulsive therapy for perinatal depression: scoping review
William V Bobo, Owen Moore, Catherine B Hurley, et al.
Clinical and Experimental Rheumatology
|
April 7, 2016
Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort Study
Claire Owen, Gene-Siew Ngian, Kathleen Elford, et al.
BMJ Open
|
March 3, 2026
Pragmatic, open-label, multicentre, randomised controlled trial to guide initial therapy for immune checkpoint inhibitor-induced inflammatory arthritis comparing standard of care (prednisolone) to adalimumab without glucocorticoids: REACT trial protocol
Benjamin A Fisher, Anna Rowe, Chris Hodson, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Community Mental Health Journal
|
August 11, 2018
Factors Associated with Rapid Readmission Among Nevada State Psychiatric Hospital Patients
Christopher Owen Moore, Sheniz Moonie, Julia Anderson
Pain
|
February 1, 1997
Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics: use of pain intensity and visual analogue scales
Andrew Moore, Owen Moore, Henry McQuay, et al.
Frontiers in Psychiatry
|
September 3, 2025
Modified electroconvulsive therapy for perinatal depression: scoping review
William V Bobo, Owen Moore, Catherine B Hurley, et al.
Clinical and Experimental Rheumatology
|
April 7, 2016
Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort Study
Claire Owen, Gene-Siew Ngian, Kathleen Elford, et al.
BMJ Open
|
March 3, 2026
Pragmatic, open-label, multicentre, randomised controlled trial to guide initial therapy for immune checkpoint inhibitor-induced inflammatory arthritis comparing standard of care (prednisolone) to adalimumab without glucocorticoids: REACT trial protocol
Benjamin A Fisher, Anna Rowe, Chris Hodson, et al.
Page
of 1